210 related articles for article (PubMed ID: 27072986)
1. The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma.
Couch G; Redman JE; Wernisch L; Newton R; Malhotra S; Dawsey SM; Lao-Sirieix P; Fitzgerald RC
Cancer Prev Res (Phila); 2016 Jul; 9(7):558-66. PubMed ID: 27072986
[TBL] [Abstract][Full Text] [Related]
2. A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China.
Liu M; Liu Z; Cai H; Guo C; Li X; Zhang C; Wang H; Hang D; Liu F; Deng Q; Yang X; Yuan W; Pan Y; Li J; Zhang C; Shen N; He Z; Ke Y
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1538-1546.e7. PubMed ID: 28342951
[TBL] [Abstract][Full Text] [Related]
3. Consistent and differential genetic aberrations between esophageal dysplasia and squamous cell carcinoma detected by array comparative genomic hybridization.
Shi ZZ; Shang L; Jiang YY; Hao JJ; Zhang Y; Zhang TT; Lin DC; Liu SG; Wang BS; Gong T; Zhan QM; Wang MR
Clin Cancer Res; 2013 Nov; 19(21):5867-78. PubMed ID: 24009147
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma.
Adams L; Roth MJ; Abnet CC; Dawsey SP; Qiao YL; Wang GQ; Wei WQ; Lu N; Dawsey SM; Woodson K
Cancer Prev Res (Phila); 2008 Oct; 1(5):357-61. PubMed ID: 19137073
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of esophageal squamous cell carcinoma in patients with squamous dysplasia: a nationwide cohort study in the Netherlands.
van Tilburg L; Spaander MCW; Bruno MJ; Oudijk L; Heij LR; Doukas M; Koch AD
Dis Esophagus; 2023 Nov; 36(12):. PubMed ID: 37480179
[TBL] [Abstract][Full Text] [Related]
6. ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction.
Shang L; Hao JJ; Zhao XK; He JZ; Shi ZZ; Liu HJ; Wu LF; Jiang YY; Shi F; Yang H; Zhang Y; Liu YZ; Zhang TT; Xu X; Cai Y; Jia XM; Li M; Zhan QM; Li EM; Wang LD; Wei WQ; Wang MR
Oncotarget; 2016 Apr; 7(17):24374-82. PubMed ID: 27016410
[TBL] [Abstract][Full Text] [Related]
7. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
8. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.
Liu M; Liu Z; Liu F; Guo C; Xu R; Li F; Liu A; Yang H; Zhang S; Shen L; Duan L; Wu Q; Cao C; Pan Y; Liu Y; Li J; Cai H; He Z; Ke Y
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1626-1635.e7. PubMed ID: 31518715
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor expression in precancerous lesions of human esophageal epithelium and prognostic significance in esophageal squamous cell carcinoma.
Li LY; Li EM; Wu ZY; Huang X; Shen JH; Xu XE; Wu JY; Huang Q; Xu LY
Dis Esophagus; 2011 Jul; 24(5):337-45. PubMed ID: 21143696
[TBL] [Abstract][Full Text] [Related]
10. Combining proteomics, serum biomarkers and bioinformatics to discriminate between esophageal squamous cell carcinoma and pre-cancerous lesion.
Zhai XH; Yu JK; Lin C; Wang LD; Zheng S
J Zhejiang Univ Sci B; 2012 Dec; 13(12):964-71. PubMed ID: 23225851
[TBL] [Abstract][Full Text] [Related]
11. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
12. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
13. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
Sun J; Song K; Feng X; Gao S
Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Liu Z; Yang T; Xu Z; Cao X
Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
Takala H; Kauppila JH; Soini Y; Selander KS; Vuopala KS; Lehenkari PP; Saarnio J; Karttunen TJ
J Innate Immun; 2011; 3(6):631-8. PubMed ID: 21876325
[TBL] [Abstract][Full Text] [Related]
17. Integrated transcriptomics explored the cancer-promoting genes CDKN3 in esophageal squamous cell cancer.
Wang W; Liao K; Guo HC; Zhou S; Yu R; Liu Y; Pan Y; Pu J
J Cardiothorac Surg; 2021 May; 16(1):148. PubMed ID: 34044866
[TBL] [Abstract][Full Text] [Related]
18. Progression of precancerous lesions of esophageal squamous cell carcinomas in a high-risk, rural Chinese population.
Gao D; Lu P; Zhang N; Zhao L; Liu J; Yang J; Liu J; Zhao D; Wang J
Cancer Med; 2023 Jan; 12(2):1791-1800. PubMed ID: 35770745
[TBL] [Abstract][Full Text] [Related]
19. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers.
Kashyap MK; Marimuthu A; Kishore CJ; Peri S; Keerthikumar S; Prasad TS; Mahmood R; Rao S; Ranganathan P; Sanjeeviah RC; Vijayakumar M; Kumar KV; Montgomery EA; Kumar RV; Pandey A
Cancer Biol Ther; 2009 Jan; 8(1):36-46. PubMed ID: 18981721
[TBL] [Abstract][Full Text] [Related]
20. Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma.
Kawakubo H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M
Oncol Rep; 2005 Dec; 14(6):1453-9. PubMed ID: 16273238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
